drugset
drugset / Trial / NCT05266651

Efficiency of Tadalafil for Management of Female Sexual Dysfunction

NCT05266651 ↗

Phase 2/3 Unknown 24 enrolled Kasr El Aini Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

comparative study between tadalafil versus placebo effect for the management of circumsized female

Timeline

Start
2022-03-10
Primary completion
2022-05
Completion
2022-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Tadalafil Small molecule 5 mg Oral

Indications

sexual disorder